Erik Samén
Impact in
-
- Cancer, Hypoxia, and Metabolism
-
- Adipose Tissue and Metabolism
Papers in
- Oncology 12
- HER2/EGFR in Cancer Research 5
- Peptidase Inhibition and Analysis 4
- CAR-T cell therapy research 2
-
- Radiopharmaceutical Chemistry and Applications 9
- Co-authors
- Sharon Stone‐Elander (11 shared papers)Annelie Falkevall (2 shared papers)Carolina E. Hagberg (2 shared papers)Ulf Eriksson (2 shared papers)Seppo Ylä‐Herttuala (1 shared paper)Li Lu (1 shared paper)Jenni Huusko (1 shared paper)Xun Wang (1 shared paper)
In The Last Decade
Erik Samén
23 papers receiving 809 citations
Peers
Comparison fields: 5 of 86
- Cancer Research 147
- Physiology 176
- Cardiology and Cardiovascular Medicine 149
- Molecular Biology 432
- Oncology 149
Countries citing papers authored by Erik Samén
This map shows the geographic impact of Erik Samén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Samén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Samén more than expected).
Fields of papers citing papers by Erik Samén
This network shows the impact of papers produced by Erik Samén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Samén. The network helps show where Erik Samén may publish in the future.
Co-authors
The 25 scholars most cited alongside Erik Samén, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 375 | |
| 2 | 2012 | 223 | |
| 3 | 2012 | 25 | |
| 4 | 2019 | 25 | |
| 5 | 2021 | 22 | |
| 6 | 2009 | 21 | |
| 7 | 2006 | 17 | |
| 8 | 2018 | 12 | |
| 9 | 2021 | 12 | |
| 10 | 2006 | 12 | |
| 11 | 2016 | 12 | |
| 12 | 2012 | 11 | |
| 13 | 2012 | 9 | |
| 14 | 2016 | 9 | |
| 15 | 2021 | 9 | |
| 16 | 2018 | 6 | |
| 17 | 2021 | 6 | |
| 18 | 2013 | 6 | |
| 19 | 2014 | 4 | |
| 20 | 2023 | 3 |
About Erik Samén
Erik Samén is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine, Surgery and Molecular Biology, having authored 23 papers that have together received 824 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (9 papers), HER2/EGFR in Cancer Research (5 papers), Cancer, Hypoxia, and Metabolism (4 papers), Angiogenesis and VEGF in Cancer (4 papers), Peptidase Inhibition and Analysis (4 papers), Lung Cancer Treatments and Mutations (3 papers), Mesenchymal stem cell research (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Cancer Research (147 citations), Physiology (176 citations), Cardiology and Cardiovascular Medicine (149 citations), Molecular Biology (432 citations) and Oncology (149 citations). Erik Samén has collaborated with scholars based in Sweden, Australia and Germany. Frequent co-authors include Sharon Stone‐Elander, Annelie Falkevall, Carolina E. Hagberg, Ulf Eriksson, Seppo Ylä‐Herttuala, Li Lu, Jenni Huusko, Xun Wang, Guillem Genové and Kristian Pietras. Their work appears in journals such as EJNMMI Research, Cell Transplantation, Nature, Journal of Nuclear Medicine and Neuroradiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.